Skip to content

Cash & Equivalents at other companies

CVS Health logo
CVS HealthCVS
$9.77B-5.6%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$888.8M+1,598%
Omnicell logo
OmnicellOMCL
$290.97M-29.8%
PACS Group logo
PACS GroupPACS
$273.71M-5.8%
Cencora logo
CencoraCOR
$2.18B+10.0%
Cardinal Health logo
Cardinal HealthCAH
$3.94B+18.4%

Other financials

Income statement

See full
Revenue$336.6M+2.2%
Gross profit$76.3M+18.6%
Operating income$17.7M+35.9%
Net income$13.3M+40.7%
EPS (diluted)$0.21+40.0%

Balance sheet

See full
Total debt$36.9M+29.6%
Total equity$232.4M+42.4%
Total assets$426.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M-65.5%
CapEx$495.0K-78.0%
Free cash flow$34.1M+69.8%

Valuation

See full
Market cap$2.48B+80.1%
Enterprise value$2.45B+76.1%
P/E46.8×
P/S1.7×+0.6×

Profitability

See full
Gross margin20.9%+1.1pp
Operating margin5.3%
Net margin3.6%+2.1pp

Returns & leverage

See full
Return on equity26.8%
Debt / equity0.2×0.0×
Current ratio1.5×+0.3×

Where this comes from

Reported directly by Guardian Pharmacy Services in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Guardian Pharmacy Services’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Guardian Pharmacy Services's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Guardian Pharmacy Services's cash & equivalents?
Guardian Pharmacy Services (GRDN) reported cash & equivalents of $64.89M in Q1 2026.
How has Guardian Pharmacy Services's cash & equivalents changed year-over-year?
Guardian Pharmacy Services's cash & equivalents increased by 363.6% year-over-year, from $14M to $64.89M.
What is the long-term trend for Guardian Pharmacy Services's cash & equivalents?
Over 2 years (2023 to 2025), Guardian Pharmacy Services's cash & equivalents has grown at a 834.1% compound annual growth rate (CAGR), from $752K to $65.62M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.